Free Trial
→ Think NVDA’s run was epic? You ain’t seen nothin’ yet (From Timothy Sykes) (Ad) Buy CIM Stock  Free CIM Stock Alerts

Chimera Investment (CIM) Financials

Chimera Investment logo
$12.35 +0.19 (+1.56%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$12.36 +0.02 (+0.12%)
As of 05/2/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Chimera Investment

Annual Income Statements for Chimera Investment

This table shows Chimera Investment's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 589 250 549 491 368 341 15 596 -587 52 90
Consolidated Net Income / (Loss)		 589 250 552 525 412 414 89 670 -513 126 176
Net Income / (Loss) Continuing Operations		 589 250 552 525 412 414 89 670 -513 126 176
Total Pre-Tax Income 		589 250 552 525 412 414 89 675 -513 126 176
Total Revenue		 644 344 645 697 542 541 212 810 -380 224 264
Net Interest Income / (Expense)		 540 613 586 606 594 602 514 611 440 263 265
Total Interest Income		 688 873 934 1,139 1,273 1,361 1,030 938 773 773 761
Investment Securities Interest Income		 688 873 934 1,139 1,273 1,361 1,030 938 773 773 761
Total Interest Expense		 148 259 348 533 679 759 516 327 333 510 496
Long-Term Debt Interest Expense		 148 259 - 533 679 759 516 327 333 510 496
Total Non-Interest Income		 104 -270 59 91 -53 -61 -302 199 -820 -39 -0.73
Net Realized & Unrealized Capital Gains on Investments		 81 -270 -27 91 -53 -61 -302 199 -820 -39 -3.44
Investment Banking Income		 - - - - - - - - 0.00 0.00 2.71
Provision for Credit Losses		 -0.23 - - - 0.00 0.00 - 0.03 7.04 11 9.84
Total Non-Interest Expense		 55 93 93 173 130 128 123 135 126 87 78
Salaries and Employee Benefits		 0.00 11 27 30 35 49 45 47 49 31 41
Other Operating Expenses		 55 83 66 81 73 74 78 89 77 56 36
Depreciation Expense		 - - - - - - - - 0.00 0.00 0.32
Income Tax Expense		 0.00 0.00 0.08 0.00 0.09 0.19 0.16 4.41 -0.25 0.10 0.05
Preferred Stock Dividends Declared		 0.00 0.00 2.45 33 43 73 74 74 74 74 86
Basic Earnings per Share		 $2.87 $1.25 $2.93 $2.62 $1.97 $1.82 $0.07 $2.55 ($7.53) $0.68 $1.12
Weighted Average Basic Shares Outstanding		 205.45M 199.56M 187.73M 187.78M 187.15M 187.16M 213.00M 233.77M 77.98M 76.69M 80.98M
Diluted Earnings per Share		 $2.87 $1.25 $2.92 $2.61 $1.96 $1.81 $0.07 $2.44 ($7.53) $0.68 $1.10
Weighted Average Diluted Shares Outstanding		 205.51M 199.65M 188.02M 188.29M 187.75M 188.41M 226.44M 245.50M 77.98M 77.54M 82.16M
Weighted Average Basic & Diluted Shares Outstanding		 205.30M 200.30M 187.50M 187.50M 187M 187.23M 230.56M 236.95M 231.83M 241.36M 80.92M
Cash Dividends to Common per Share		 $1.80 $1.92 $2.44 $2.00 $2.00 $2.00 $1.40 $1.29 - $2.10 $1.42

Quarterly Income Statements for Chimera Investment

This table shows Chimera Investment's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -205 79 39 18 -16 12 111 34 114 -168
Consolidated Net Income / (Loss)		 -186 97 57 36 2.17 31 129 57 136 -147
Net Income / (Loss) Continuing Operations		 -186 97 57 36 2.17 31 129 57 136 -147
Total Pre-Tax Income 		-186 97 57 36 2.25 31 129 57 136 -147
Total Revenue		 -162 140 92 70 26 37 153 81 159 -130
Net Interest Income / (Expense)		 105 80 70 66 63 65 65 67 66 66
Total Interest Income		 188 187 189 197 196 191 187 187 195 192
Investment Securities Interest Income		 188 187 189 197 196 191 187 187 195 192
Total Interest Expense		 83 107 120 131 132 127 121 119 129 127
Long-Term Debt Interest Expense		 83 107 120 131 132 127 121 119 129 127
Total Non-Interest Income		 -267 60 22 4.15 -37 -28 88 14 93 -196
Net Realized & Unrealized Capital Gains on Investments		 -267 60 22 4.15 -37 -28 88 14 93 -198
Provision for Credit Losses		 -1.53 - 3.06 2.76 3.22 2.33 1.35 3.68 0.36 4.45
Total Non-Interest Expense		 26 39 31 31 21 3.64 23 21 22 12
Salaries and Employee Benefits		 10 19 10 7.68 7.12 5.28 9.21 7.01 7.20 18
Other Operating Expenses		 16 20 21 23 14 -1.64 13 14 15 -6.15
Income Tax Expense		 0.00 -0.28 0.00 0.03 0.08 0.00 0.01 0.03 0.02 -0.01
Preferred Stock Dividends Declared		 18 18 18 18 18 18 18 23 23 22
Basic Earnings per Share		 ($0.88) $1.01 $0.17 $0.23 ($0.22) $0.16 $0.46 $0.42 $1.41 ($2.08)
Weighted Average Basic Shares Outstanding		 231.75M 77.98M 231.99M 77.21M 75.58M 76.69M 243.72M 81.33M 80.81M 80.98M
Diluted Earnings per Share		 ($0.88) $1.01 $0.17 $0.23 ($0.22) $0.16 $0.45 $0.41 $1.39 ($2.08)
Weighted Average Diluted Shares Outstanding		 231.75M 77.98M 235.20M 77.96M 75.58M 77.54M 245.15M 82.28M 81.86M 82.16M
Basic & Diluted Earnings per Share		 - $1.01 - - - $0.16 - - - ($2.08)
Weighted Average Basic & Diluted Shares Outstanding		 231.75M 231.83M 232.10M 226.75M 226.76M 241.36M 241.42M 80.53M 80.88M 80.92M
Cash Dividends to Common per Share		 $0.23 $0.92 $0.23 $0.54 $0.54 $0.56 $0.11 $0.35 $0.37 $0.64

Annual Cash Flow Statements for Chimera Investment

This table details how cash moves in and out of Chimera Investment's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 87 -51 64 -114 -16 62 159 117 -121 -43 -138
Net Cash From Operating Activities		 183 396 553 487 298 65 258 519 326 213 206
Net Cash From Continuing Operating Activities		 183 396 553 487 298 65 258 519 326 213 206
Net Income / (Loss) Continuing Operations		 589 250 552 525 412 414 89 670 -513 126 176
Consolidated Net Income / (Loss)		 589 250 552 525 412 414 89 670 -513 126 176
Provision For Loan Losses		 -0.23 - - - 0.00 0.00 0.18 0.03 7.04 11 9.87
Depreciation Expense		 - - - - - - - - 0.00 0.00 0.32
Amortization Expense		 -61 21 -1.58 -18 16 29 63 79 61 48 19
Non-Cash Adjustments to Reconcile Net Income		 -168 76 -61 -61 103 -317 -198 -193 822 -13 17
Changes in Operating Assets and Liabilities, net		 -177 49 63 42 -233 -61 304 -38 -51 40 -16
Net Cash From Investing Activities		 -5,779 2,038 -1,271 -4,331 -6,026 1,237 8,330 2,548 510 552 178
Net Cash From Continuing Investing Activities		 -5,779 2,038 -1,271 -4,331 -6,026 1,237 8,330 2,548 510 552 178
Purchase of Investment Securities		 -10,000 -7,833 -6,141 -7,860 -9,722 -7,670 -3,025 -3,080 -2,148 -1,266 -1,852
Sale and/or Maturity of Investments		 4,221 9,868 4,871 3,529 3,696 8,906 11,355 5,628 2,658 1,818 2,031
Net Cash From Financing Activities		 5,683 -2,485 781 3,730 5,712 -1,240 -8,429 -2,951 -957 -808 -522
Net Cash From Continuing Financing Activities		 5,683 -2,485 781 3,730 5,712 -1,240 -8,429 -2,951 -957 -808 -522
Issuance of Debt		 44 1,483 4,797 5,152 1,770 1,487 3,404 5,522 1,123 2,186 474
Issuance of Common Equity		 0.00 - - - - - - 0.00 0.00 74 0.00
Repayment of Debt		 -583 -2,321 -1,863 -2,975 -2,657 -1,870 -2,553 -6,462 -1,847 -1,767 -1,171
Repurchase of Common Equity		 0.00 -250 0.00 0.00 -15 0.00 -22 -1.83 -49 -33 0.00
Payment of Dividends		 -575 -381 -454 -412 -418 -447 -396 -372 -362 -251 -223
Other Financing Activities, Net		 6,797 -1,016 -1,838 1,650 6,781 -604 -8,862 -1,636 178 -1,017 398
Cash Interest Paid		 111 237 335 512 644 835 578 339 323 470 479
Cash Interest Received		 577 881 917 1,092 1,279 1,427 1,168 1,020 842 774 761
Cash Income Taxes Paid		 - - - - - 0.19 0.16 4.41 -0.25 0.10 0.05

Quarterly Cash Flow Statements for Chimera Investment

This table details how cash moves in and out of Chimera Investment's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Change in Cash & Equivalents		 -72 178 -32 -31 -62 83 -53 -6.65 -65 -13
Net Cash From Operating Activities		 41 26 30 107 45 31 57 69 41 38
Net Cash From Continuing Operating Activities		 41 26 30 107 45 31 57 69 41 38
Net Income / (Loss) Continuing Operations		 -186 97 57 36 2.17 31 129 57 136 -147
Consolidated Net Income / (Loss)		 -186 97 57 36 2.17 31 129 57 136 -147
Provision For Loan Losses		 -1.53 3.83 3.06 2.76 3.22 2.33 1.35 3.69 0.36 4.48
Amortization Expense		 14 -4.60 11 20 14 3.95 9.70 13 -1.96 -2.42
Non-Cash Adjustments to Reconcile Net Income		 269 -57 -68 -8.12 44 19 -83 -4.44 -88 192
Changes in Operating Assets and Liabilities, net		 -55 -13 28 57 -19 -25 -0.51 -0.25 -5.74 -9.58
Net Cash From Investing Activities		 486 -146 -82 -111 368 377 248 -114 -646 690
Net Cash From Continuing Investing Activities		 486 -146 -82 -111 368 377 248 -114 -646 690
Purchase of Investment Securities		 -67 -623 -591 -639 -36 -0.08 -111 -461 -1,033 -247
Sale and/or Maturity of Investments		 554 478 509 528 404 377 360 347 387 937
Net Cash From Financing Activities		 -599 298 19 -27 -475 -325 -358 38 540 -741
Net Cash From Continuing Financing Activities		 -599 298 19 -27 -475 -325 -358 38 540 -741
Issuance of Debt		 274 94 944 1,103 - 139 0.00 62 412 -0.00
Repayment of Debt		 -445 -346 -609 -528 -324 -305 -273 -295 -307 -296
Payment of Dividends		 -96 -72 -73 -72 -62 -43 -45 -46 -80 -52
Other Financing Activities, Net		 -328 621 -242 -504 -81 -190 -40 316 515 -393
Cash Interest Paid		 81 99 112 115 125 119 120 114 124 122
Cash Interest Received		 204 188 181 207 199 186 188 209 182 182

Annual Balance Sheets for Chimera Investment

This table presents Chimera Investment's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 19,155 15,345 16,685 21,222 27,709 27,119 17,523 15,407 13,402 12,929 13,116
Cash and Due from Banks		 165 114 178 64 47 110 269 386 265 222 84
Trading Account Securities		 16,549 11,299 16,261 7,265 2,524 3.61 1,831 0.00 12,942 102 12,780
Loans and Leases, Net of Allowance		 626 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets		 1,816 3,932 246 215 12,565 12,712 2,311 2,760 196 1,208 252
Total Liabilities & Shareholders' Equity		 19,155 15,345 16,685 21,222 27,709 27,119 17,523 15,407 13,402 12,929 13,116
Total Liabilities		 15,547 12,398 13,561 17,587 24,005 23,165 13,744 11,671 10,735 10,370 10,590
Short-Term Debt		 8,470 7,449 5,603 7,250 14,030 13,428 4,637 3,262 3,435 2,432 2,824
Accrued Interest Payable		 32 37 49 62 110 64 41 20 31 38 41
Other Short-Term Payables		 92 - 97 - - - - - 65 - 34
Long-Term Debt		 5,095 4,250 7,275 9,594 8,615 8,313 8,877 7,814 7,179 7,677 7,190
Other Long-Term Liabilities		 1,858 662 537 680 1,249 1,361 189 575 26 223 500
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 3,608 2,946 3,124 3,635 3,704 3,953 3,779 3,736 2,667 2,559 2,526
Total Preferred & Common Equity		 3,608 2,946 3,124 3,635 3,704 3,953 3,779 3,736 2,667 2,559 2,526
Preferred Stock		 - 0.00 0.06 0.19 0.29 0.37 0.37 0.37 0.37 0.37 0.37
Total Common Equity		 3,608 2,946 3,123 3,635 3,704 3,953 3,779 3,736 2,666 2,559 2,526
Common Stock		 3,616 3,368 3,511 3,829 4,074 4,278 4,540 4,361 4,321 4,371 4,391
Retained Earnings		 -1,055 -1,196 -1,105 -991 -997 -1,033 -1,319 -1,031 -1,884 -1,998 -2,025
Accumulated Other Comprehensive Income / (Loss)		 1,047 774 718 797 627 708 558 405 229 186 159

Quarterly Balance Sheets for Chimera Investment

This table presents Chimera Investment's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024
Total Assets		 13,669 14,204 13,510 12,887 12,547 13,132 13,702
Cash and Due from Banks		 86 232 201 139 169 162 97
Trading Account Securities		 13,369 278 143 128 66 12,793 13,425
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets		 200 1,311 1,237 1,194 1,237 176 180
Total Liabilities & Shareholders' Equity		 13,669 14,204 13,510 12,887 12,547 13,132 13,702
Total Liabilities		 11,016 11,554 10,930 10,393 9,901 10,491 10,965
Short-Term Debt		 2,821 3,195 2,687 2,604 2,385 2,699 3,229
Accrued Interest Payable		 26 31 37 36 35 39 40
Other Short-Term Payables		 64 - - - - 61 34
Long-Term Debt		 7,434 7,585 8,118 7,675 7,410 7,214 7,521
Other Long-Term Liabilities		 671 743 88 79 71 477 142
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,654 2,649 2,579 2,494 2,646 2,641 2,737
Total Preferred & Common Equity		 2,654 2,649 2,579 2,494 2,646 2,641 2,737
Preferred Stock		 0.37 0.37 0.37 0.37 0.37 0.37 0.37
Total Common Equity		 2,653 2,649 2,579 2,494 2,645 2,641 2,737
Common Stock		 4,317 4,323 4,292 4,294 4,374 4,376 4,380
Retained Earnings		 -1,908 -1,899 -1,923 -1,981 -1,914 -1,910 -1,826
Accumulated Other Comprehensive Income / (Loss)		 244 225 211 181 185 174 184

Annual Metrics and Ratios for Chimera Investment

This table displays calculated financial ratios and metrics derived from Chimera Investment's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 55.23% -46.65% 87.65% 8.13% -22.34% -0.08% -60.85% 282.31% -146.95% 158.92% 17.78%
EBITDA Growth		 76.70% -48.63% 102.88% -7.94% -15.69% 3.74% -65.68% 395.52% -159.98% 138.57% 11.91%
EBIT Growth		 62.84% -57.51% 120.50% -4.94% -21.54% 0.49% -78.44% 656.26% -176.10% 124.59% 39.54%
NOPAT Growth		 62.46% -57.51% 120.47% -4.92% -21.56% 0.47% -78.51% 654.17% -153.62% 135.09% 39.62%
Net Income Growth		 62.46% -57.51% 120.47% -4.94% -21.54% 0.47% -78.51% 654.17% -176.56% 124.58% 39.62%
EPS Growth		 62.46% -56.45% 133.60% -10.62% -24.90% -7.65% -96.13% 3,385.71% -176.56% 124.58% 61.76%
Operating Cash Flow Growth		 -40.04% 116.82% 39.52% -11.87% -38.93% -78.15% 296.55% 101.31% -37.26% -34.52% -3.56%
Free Cash Flow Firm Growth		 -842.51% 127.81% -128.98% -391.07% -38.07% 119.59% 694.06% -62.88% -62.82% -36.93% -58.99%
Invested Capital Growth		 160.44% -14.72% 9.27% 27.98% 28.66% -2.49% -32.70% -14.35% -10.34% -4.62% -1.00%
Revenue Q/Q Growth		 0.83% 11.53% 0.00% 0.00% -32.81% 74.94% 6.80% -13.88% 19.60% -31.22% -41.03%
EBITDA Q/Q Growth		 -12.01% 108.90% 4,839.36% 4,917.46% -32.02% 108.83% 22.73% -14.91% 12.27% -28.85% -48.41%
EBIT Q/Q Growth		 -9.91% 77.64% 0.00% 0.00% -33.81% 129.09% 23.70% -16.18% 12.99% -38.57% -50.13%
NOPAT Q/Q Growth		 -10.05% 76.98% 0.00% 0.00% -33.84% 129.20% 23.52% -16.20% 13.47% -34.58% -50.14%
Net Income Q/Q Growth		 -10.05% 76.98% 0.00% 0.00% -33.83% 129.20% 23.52% -16.20% 13.41% -34.58% -50.14%
EPS Q/Q Growth		 -10.05% 73.61% 0.00% 0.00% -36.98% 206.78% 112.96% -20.78% 13.41% -34.58% -67.16%
Operating Cash Flow Q/Q Growth		 -24.14% 40.86% 36.10% -18.54% -55.44% 119.30% -33.94% 6.53% -20.24% 2.35% 3.33%
Free Cash Flow Firm Q/Q Growth		 -158.76% 179.22% 40.68% -2.97% -72.99% 139.51% -12.17% 27.82% -50.20% 124.79% 183.93%
Invested Capital Q/Q Growth		 50.25% -2.87% -2.63% 1.02% 9.56% -4.61% -0.29% -5.52% 2.88% -0.82% -7.02%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 81.97% 78.93% 85.33% 72.66% 78.87% 81.89% 71.79% 93.05% 0.00% 77.81% 73.93%
EBIT Margin		 91.44% 72.83% 85.58% 75.24% 76.01% 76.44% 42.10% 83.27% 0.00% 56.32% 66.72%
Profit (Net Income) Margin		 91.44% 72.83% 85.57% 75.23% 75.99% 76.41% 41.94% 82.73% 0.00% 56.27% 66.71%
Tax Burden Percent		 100.00% 100.00% 99.99% 99.98% 99.98% 99.95% 99.82% 99.35% 99.95% 99.92% 99.97%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 99.80% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.02% 0.00% 0.02% 0.05% 0.18% 0.65% 0.00% 0.08% 0.03%
Return on Invested Capital (ROIC)		 4.96% 1.57% 3.60% 2.88% 1.76% 1.59% 0.41% 4.17% 0.00% 0.97% 1.40%
ROIC Less NNEP Spread (ROIC-NNEP)		 4.96% 1.57% 3.60% 2.88% 1.76% 1.59% 0.41% 4.17% 0.00% 0.97% 1.40%
Return on Net Nonoperating Assets (RNNOA)		 12.02% 6.07% 14.58% 12.65% 9.46% 9.21% 1.88% 13.66% 0.00% 3.85% 5.53%
Return on Equity (ROE)		 16.98% 7.64% 18.19% 15.53% 11.22% 10.80% 2.30% 17.83% -16.03% 4.83% 6.92%
Cash Return on Invested Capital (CROIC)		 -84.06% 17.46% -5.25% -21.67% -23.31% 4.11% 39.50% 19.63% 8.34% 5.70% 2.40%
Operating Return on Assets (OROA)		 4.52% 1.45% 3.45% 2.77% 1.68% 1.51% 0.40% 4.10% 0.00% 0.96% 1.35%
Return on Assets (ROA)		 4.52% 1.45% 3.45% 2.77% 1.68% 1.51% 0.40% 4.07% 0.00% 0.96% 1.35%
Return on Common Equity (ROCE)		 16.98% 7.64% 18.19% 15.53% 11.22% 10.80% 2.30% 17.83% -16.02% 4.83% 6.92%
Return on Equity Simple (ROE_SIMPLE)		 16.33% 8.50% 17.67% 14.43% 11.11% 10.46% 2.35% 17.94% -19.24% 4.93% 6.97%
Net Operating Profit after Tax (NOPAT)		 589 250 552 525 412 414 89 670 -359 126 176
NOPAT Margin		 91.44% 72.83% 85.57% 75.24% 75.99% 76.41% 41.94% 82.73% 0.00% 56.27% 66.71%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.42% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 3.07% 4.17% 4.33% 6.48% 9.03% 21.15% 5.78% 0.00% 13.64% 15.67%
Operating Expenses to Revenue		 8.60% 27.17% 14.42% 24.76% 23.99% 23.56% 57.90% 16.73% 0.00% 38.61% 29.55%
Earnings before Interest and Taxes (EBIT)		 589 250 552 525 412 414 89 675 -513 126 176
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 528 271 550 507 427 443 152 754 -452 174 195
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.29 0.32 0.43 0.45 0.47 0.56 0.42 0.69 0.38 0.40 0.45
Price to Tangible Book Value (P/TBV)		 0.29 0.32 0.43 0.45 0.47 0.56 0.42 0.69 0.38 0.40 0.45
Price to Revenue (P/Rev)		 1.60 2.70 2.10 2.34 3.23 4.13 7.51 3.20 0.00 4.56 4.29
Price to Earnings (P/E)		 1.75 3.71 2.46 3.32 4.74 6.55 105.30 4.34 0.00 19.51 12.53
Dividend Yield		 55.68% 39.04% 33.84% 23.05% 21.40% 16.76% 20.57% 11.79% 25.60% 15.54% 10.14%
Earnings Yield		 57.02% 26.93% 40.60% 30.14% 21.08% 15.26% 0.95% 23.02% 0.00% 5.13% 7.98%
Enterprise Value to Invested Capital (EV/IC)		 0.84 0.85 0.88 0.90 0.92 0.93 0.86 0.90 0.86 0.86 0.88
Enterprise Value to Revenue (EV/Rev)		 22.40 36.41 21.79 26.40 44.95 44.09 70.02 16.40 0.00 48.68 41.92
Enterprise Value to EBITDA (EV/EBITDA)		 27.33 46.13 25.53 36.33 56.99 53.84 97.53 17.62 0.00 62.56 56.70
Enterprise Value to EBIT (EV/EBIT)		 24.50 49.99 25.46 35.08 59.13 57.68 166.33 19.69 0.00 86.44 62.82
Enterprise Value to NOPAT (EV/NOPAT)		 24.50 49.99 25.46 35.08 59.15 57.71 166.96 19.82 0.00 86.51 62.84
Enterprise Value to Operating Cash Flow (EV/OCF)		 78.97 31.58 25.42 37.78 81.81 366.94 57.52 25.58 34.89 51.15 53.79
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 4.51 0.00 0.00 0.00 22.32 1.75 4.21 9.70 14.76 36.51
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 3.76 3.97 4.12 4.63 6.11 5.50 3.58 2.96 3.98 3.95 3.96
Long-Term Debt to Equity		 1.41 1.44 2.33 2.64 2.33 2.10 2.35 2.09 2.69 3.00 2.85
Financial Leverage		 2.42 3.85 4.05 4.40 5.38 5.80 4.56 3.27 3.39 3.97 3.96
Leverage Ratio		 3.76 5.26 5.28 5.61 6.67 7.16 5.77 4.38 4.50 5.04 5.12
Compound Leverage Factor		 3.76 5.26 5.28 5.61 6.67 7.16 5.76 4.38 4.50 5.04 5.12
Debt to Total Capital		 78.99% 79.88% 80.48% 82.25% 85.94% 84.61% 78.15% 74.78% 79.92% 79.80% 79.86%
Short-Term Debt to Total Capital		 49.32% 50.86% 35.02% 35.40% 53.25% 52.26% 26.81% 22.02% 25.86% 19.20% 22.52%
Long-Term Debt to Total Capital		 29.67% 29.02% 45.46% 46.85% 32.70% 32.35% 51.33% 52.76% 54.06% 60.60% 57.34%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 21.01% 20.12% 19.52% 17.75% 14.06% 15.38% 21.85% 25.22% 20.08% 20.20% 20.14%
Debt to EBITDA		 25.68 43.12 23.40 33.24 53.01 49.05 88.84 14.69 -23.48 57.97 51.32
Net Debt to EBITDA		 25.37 42.70 23.07 33.12 52.89 48.80 87.07 14.18 -22.89 56.70 50.89
Long-Term Debt to EBITDA		 9.65 15.66 13.22 18.93 20.17 18.76 58.36 10.37 -15.88 44.03 36.85
Debt to NOPAT		 23.02 46.73 23.33 32.10 55.01 52.57 152.09 16.53 -29.54 80.16 56.88
Net Debt to NOPAT		 22.74 46.27 23.01 31.98 54.90 52.31 149.06 15.95 -28.80 78.41 56.40
Long-Term Debt to NOPAT		 8.65 16.98 13.18 18.28 20.93 20.10 99.90 11.66 -19.98 60.88 40.84
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -9,990 2,778 -805 -3,953 -5,458 1,069 8,490 3,151 1,172 739 303
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 -67.60 10.71 -2.31 -7.42 -8.04 1.41 16.45 9.65 3.52 1.45 0.61
Operating Cash Flow to Interest Expense		 1.24 1.53 1.59 0.91 0.44 0.09 0.50 1.59 0.98 0.42 0.41
Operating Cash Flow Less CapEx to Interest Expense		 1.24 1.53 1.59 0.91 0.44 0.09 0.50 1.59 0.98 0.42 0.41
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.05 0.02 0.04 0.04 0.02 0.02 0.01 0.05 0.00 0.02 0.02
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 17,173 14,645 16,002 20,480 26,350 25,694 17,293 14,812 13,281 12,668 12,541
Invested Capital Turnover		 0.05 0.02 0.04 0.04 0.02 0.02 0.01 0.05 0.00 0.02 0.02
Increase / (Decrease) in Invested Capital		 10,579 -2,527 1,357 4,478 5,870 -656 -8,401 -2,481 -1,531 -613 -127
Enterprise Value (EV)		 14,434 12,514 14,054 18,411 24,347 23,864 14,835 13,281 11,364 10,909 11,063
Market Capitalization		 1,033 930 1,354 1,630 1,748 2,233 1,590 2,591 1,014 1,021 1,132
Book Value per Share		 $3.51 $15.59 $16.64 $19.36 $19.80 $21.12 $16.17 $15.77 $11.51 $11.28 $31.23
Tangible Book Value per Share		 $3.51 $15.59 $16.64 $19.36 $19.80 $21.12 $16.17 $15.77 $11.51 $11.28 $31.23
Total Capital		 17,173 14,645 16,002 20,480 26,350 25,694 17,293 14,812 13,281 12,668 12,541
Total Debt		 13,565 11,699 12,878 16,845 22,646 21,741 13,514 11,076 10,614 10,109 10,015
Total Long-Term Debt		 5,095 4,250 7,275 9,594 8,615 8,313 8,877 7,814 7,179 7,677 7,190
Net Debt		 13,400 11,585 12,701 16,781 22,598 21,631 13,244 10,690 10,349 9,887 9,931
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 0.00 0.00 0.00 0.11 0.00 0.00 0.00 0.00 154 0.00 0.00
Net Nonoperating Obligations (NNO)		 13,565 11,699 12,878 16,845 22,646 21,741 13,514 11,076 10,614 10,109 10,015
Total Depreciation and Amortization (D&A)		 -61 21 -1.58 -18 16 29 63 79 61 48 19
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.69 $1.12
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 76.69M 80.98M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.69 $1.10
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 77.54M 82.16M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 80.45M 80.92M
Normalized Net Operating Profit after Tax (NOPAT)		 412 175 552 411 433 418 89 670 -359 126 176
Normalized NOPAT Margin		 64.01% 50.98% 85.57% 58.88% 80.01% 77.30% 41.94% 82.73% 0.00% 56.27% 66.71%
Pre Tax Income Margin		 91.44% 72.83% 85.58% 75.24% 76.01% 76.44% 42.01% 83.27% 0.00% 56.32% 66.72%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 3.99 0.97 1.59 0.99 0.61 0.55 0.17 2.07 -1.54 0.25 0.35
NOPAT to Interest Expense		 3.99 0.97 1.59 0.99 0.61 0.55 0.17 2.05 -1.08 0.25 0.35
EBIT Less CapEx to Interest Expense		 3.99 0.97 1.59 0.99 0.61 0.55 0.17 2.07 -1.54 0.25 0.35
NOPAT Less CapEx to Interest Expense		 3.99 0.97 1.59 0.99 0.61 0.55 0.17 2.05 -1.08 0.25 0.35
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 97.64% 152.26% 82.30% 78.47% 101.45% 108.08% 446.10% 55.57% -70.46% 198.67% 126.80%
Augmented Payout Ratio		 97.64% 252.12% 82.30% 78.47% 105.05% 108.08% 470.93% 55.85% -79.99% 224.92% 126.80%

Quarterly Metrics and Ratios for Chimera Investment

This table displays calculated financial ratios and metrics derived from Chimera Investment's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 -144.61% 196.23% 139.37% 155.46% 116.20% -73.92% 67.69% 16.20% 507.03% -455.94%
EBITDA Growth		 -148.61% 273.04% 128.39% 141.80% 109.50% -64.12% 104.71% 26.11% 723.66% -531.74%
EBIT Growth		 -155.93% 492.94% 121.84% 122.36% 101.21% -69.68% 125.68% 57.27% 5,979.06% -579.66%
NOPAT Growth		 -139.31% 448.10% 131.18% 131.92% 101.67% -68.58% 125.66% 57.30% 6,188.43% -435.79%
Net Income Growth		 -156.16% 448.10% 121.83% 122.33% 101.17% -68.58% 125.66% 57.30% 6,188.43% -579.68%
EPS Growth		 -167.69% 0.00% 114.29% 122.33% 101.17% -68.58% 164.71% 78.26% 731.82% -1,400.00%
Operating Cash Flow Growth		 -73.02% -75.77% -77.60% -12.97% 9.97% 18.51% 88.15% -35.37% -7.31% 21.14%
Free Cash Flow Firm Growth		 32.05% -34.84% 1.14% -67.91% -94.76% -60.48% -24.53% 65.02% -518.10% -96.21%
Invested Capital Growth		 -17.66% -10.34% -9.60% -3.61% -1.05% -4.62% -7.37% -6.20% 5.59% -1.00%
Revenue Q/Q Growth		 -28.67% 186.42% -33.79% -23.71% -62.42% 39.14% 162.02% -47.13% 96.33% -181.58%
EBITDA Q/Q Growth		 -29.28% 155.95% -29.30% -18.26% -70.61% 111.23% 303.38% -49.64% 91.97% -210.72%
EBIT Q/Q Growth		 -15.45% 154.13% -43.06% -37.16% -93.77% 1,260.62% 323.83% -56.21% 140.72% -207.36%
NOPAT Q/Q Growth		 -15.45% 174.60% -40.98% -37.20% -93.98% 1,307.56% 323.83% -56.23% 140.82% -175.16%
Net Income Q/Q Growth		 -15.38% 152.22% -40.98% -37.20% -93.98% 1,307.56% 323.83% -56.23% 140.82% -207.37%
EPS Q/Q Growth		 -15.79% 152.22% -50.00% -37.20% -93.98% 1,307.56% 800.00% -8.89% 239.02% -249.64%
Operating Cash Flow Q/Q Growth		 -66.90% -34.94% 15.15% 250.91% -58.17% -29.89% 82.83% 20.53% -40.00% -8.37%
Free Cash Flow Firm Q/Q Growth		 57.49% -38.27% -8.91% -63.76% -74.29% 365.69% 73.96% -20.76% -165.13% 104.23%
Invested Capital Q/Q Growth		 -7.04% 2.88% 1.12% -0.34% -4.57% -0.82% -1.80% 0.92% 7.43% -7.02%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 0.00% 68.68% 74.27% 79.58% 62.24% 94.48% 90.67% 86.36% 84.45% 0.00%
EBIT Margin		 0.00% 71.97% 62.68% 51.63% 8.56% 83.66% 84.36% 69.88% 85.67% 0.00%
Profit (Net Income) Margin		 0.00% 69.43% 62.68% 51.59% 8.27% 83.65% 84.35% 69.84% 85.66% 0.00%
Tax Burden Percent		 100.00% 100.29% 100.00% 99.93% 96.66% 99.99% 99.99% 99.95% 99.99% 100.00%
Interest Burden Percent		 100.00% 96.19% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% -0.29% 0.00% 0.07% 3.34% 0.01% 0.01% 0.05% 0.01% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.52% 0.21% 1.44% 1.98% 1.69% 2.92% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.52% 0.21% 1.44% 1.98% 1.69% 2.92% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 2.04% 0.84% 5.73% 7.68% 6.72% 11.74% 0.00%
Return on Equity (ROE)		 -18.23% -16.03% -6.45% 2.56% 1.05% 7.17% 9.66% 8.42% 14.66% 0.00%
Cash Return on Invested Capital (CROIC)		 16.46% 8.34% 9.13% 3.71% 2.56% 5.70% 9.19% 8.09% -2.75% 2.40%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.52% 0.21% 1.42% 1.91% 1.65% 2.88% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.52% 0.20% 1.42% 1.91% 1.65% 2.88% 0.00%
Return on Common Equity (ROCE)		 -18.22% -16.02% -6.44% 2.56% 1.05% 7.17% 9.66% 8.41% 14.66% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 -22.33% 0.00% -7.28% 0.17% 7.73% 0.00% 7.49% 8.29% 12.90% 0.00%
Net Operating Profit after Tax (NOPAT)		 -130 97 57 36 2.17 31 129 57 136 -103
NOPAT Margin		 0.00% 69.43% 62.68% 51.59% 8.27% 83.65% 84.35% 69.84% 85.66% 0.00%
Net Nonoperating Expense Percent (NNEP)		 0.51% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.44%
SG&A Expenses to Revenue		 0.00% 13.69% 11.46% 10.99% 27.15% 14.46% 6.00% 8.64% 4.52% 0.00%
Operating Expenses to Revenue		 0.00% 28.03% 33.98% 44.42% 79.19% 9.96% 14.77% 25.58% 14.10% 0.00%
Earnings before Interest and Taxes (EBIT)		 -186 101 57 36 2.25 31 129 57 136 -147
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -172 96 68 56 16 34 139 70 135 -149
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.37 0.38 0.43 0.47 0.45 0.40 0.40 0.39 0.47 0.45
Price to Tangible Book Value (P/TBV)		 0.37 0.38 0.43 0.47 0.45 0.40 0.40 0.39 0.47 0.45
Price to Revenue (P/Rev)		 0.00 0.00 0.00 8.75 3.45 4.56 3.48 3.27 2.85 4.29
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 9.45 19.51 8.48 7.32 4.71 12.53
Dividend Yield		 29.11% 25.60% 20.76% 16.78% 16.54% 15.54% 16.00% 12.11% 8.72% 10.14%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 10.58% 5.13% 11.79% 13.67% 21.24% 7.98%
Enterprise Value to Invested Capital (EV/IC)		 0.86 0.86 0.87 0.88 0.88 0.86 0.86 0.86 0.88 0.88
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 85.82 34.57 48.68 35.23 34.28 26.65 41.92
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 226.47 45.96 62.56 43.50 41.46 31.53 56.70
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 958.69 54.83 86.44 53.86 49.24 33.77 62.82
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 2,656.50 58.44 86.51 53.89 49.27 33.78 62.84
Enterprise Value to Operating Cash Flow (EV/OCF)		 27.28 34.89 53.07 57.79 54.06 51.15 44.49 53.29 59.92 53.79
Enterprise Value to Free Cash Flow (EV/FCFF)		 4.74 9.70 9.06 23.34 34.26 14.76 8.99 10.28 0.00 36.51
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 3.86 3.98 4.07 4.19 4.12 3.95 3.70 3.75 3.93 3.96
Long-Term Debt to Equity		 2.80 2.69 2.86 3.15 3.08 3.00 2.80 2.73 2.75 2.85
Financial Leverage		 3.40 3.39 3.73 3.91 3.99 3.97 3.89 3.97 4.02 3.96
Leverage Ratio		 4.56 4.50 4.92 4.96 5.16 5.04 5.05 5.10 5.08 5.12
Compound Leverage Factor		 4.56 4.33 4.92 4.96 5.16 5.04 5.05 5.10 5.08 5.12
Debt to Total Capital		 79.44% 79.92% 80.27% 80.73% 80.47% 79.80% 78.73% 78.96% 79.70% 79.86%
Short-Term Debt to Total Capital		 21.85% 25.86% 23.79% 20.07% 20.39% 19.20% 19.17% 21.50% 23.94% 22.52%
Long-Term Debt to Total Capital		 57.59% 54.06% 56.48% 60.66% 60.08% 60.60% 59.56% 57.46% 55.76% 57.34%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 20.55% 20.08% 19.73% 19.27% 19.53% 20.20% 21.26% 21.04% 20.29% 20.14%
Debt to EBITDA		 -19.90 -23.48 -80.09 207.23 41.94 57.97 39.89 38.12 28.42 51.32
Net Debt to EBITDA		 -19.73 -22.89 -78.36 203.37 41.38 56.70 39.20 37.49 28.16 50.89
Long-Term Debt to EBITDA		 -14.43 -15.88 -56.35 155.70 31.32 44.03 30.18 27.74 19.88 36.85
Debt to NOPAT		 -24.70 -29.54 -79.76 2,430.82 53.32 80.16 49.42 45.30 30.44 56.88
Net Debt to NOPAT		 -24.49 -28.80 -78.04 2,385.61 52.60 78.41 48.57 44.56 30.17 56.40
Long-Term Debt to NOPAT		 -17.90 -19.98 -56.12 1,826.43 39.81 60.88 37.39 32.96 21.30 40.84
Noncontrolling Interest Sharing Ratio		 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 2,638 1,628 1,483 537 138 643 1,119 887 -578 24
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 31.60 15.23 12.40 4.10 1.05 5.08 9.22 7.43 -4.48 0.19
Operating Cash Flow to Interest Expense		 0.49 0.25 0.25 0.81 0.34 0.25 0.47 0.58 0.32 0.30
Operating Cash Flow Less CapEx to Interest Expense		 0.49 0.25 0.25 0.81 0.34 0.25 0.47 0.58 0.32 0.30
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.01 0.02 0.02 0.02 0.02 0.03 0.02
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 12,909 13,281 13,430 13,384 12,773 12,668 12,440 12,554 13,487 12,541
Invested Capital Turnover		 0.00 0.00 0.00 0.01 0.03 0.02 0.02 0.02 0.03 0.02
Increase / (Decrease) in Invested Capital		 -2,768 -1,531 -1,426 -501 -136 -613 -990 -830 714 -127
Enterprise Value (EV)		 11,141 11,364 11,688 11,808 11,264 10,909 10,681 10,781 11,928 11,063
Market Capitalization		 971 1,014 1,139 1,204 1,124 1,021 1,056 1,030 1,275 1,132
Book Value per Share		 $11.45 $11.51 $11.43 $11.11 $11.00 $11.28 $10.96 $10.94 $33.99 $31.23
Tangible Book Value per Share		 $11.45 $11.51 $11.43 $11.11 $11.00 $11.28 $10.96 $10.94 $33.99 $31.23
Total Capital		 12,909 13,281 13,430 13,384 12,773 12,668 12,440 12,554 13,487 12,541
Total Debt		 10,255 10,614 10,780 10,805 10,278 10,109 9,794 9,913 10,750 10,015
Total Long-Term Debt		 7,434 7,179 7,585 8,118 7,675 7,677 7,410 7,214 7,521 7,190
Net Debt		 10,169 10,349 10,548 10,604 10,140 9,887 9,625 9,751 10,652 9,931
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 56 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 44
Net Nonoperating Obligations (NNO)		 10,255 10,614 10,780 10,805 10,278 10,109 9,794 9,913 10,750 10,015
Total Depreciation and Amortization (D&A)		 14 -4.60 11 20 14 3.95 9.70 13 -1.96 -2.42
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($2.64) $3.03 $0.51 $0.24 ($0.21) $0.48 $1.38 $0.42 $1.41 ($2.08)
Adjusted Weighted Average Basic Shares Outstanding		 77.25M 25.99M 77.33M 77.21M 75.58M 25.56M 81.24M 81.33M 80.81M 80.98M
Adjusted Diluted Earnings per Share		 ($2.64) $3.03 $0.51 $0.24 ($0.21) $0.48 $1.35 $0.41 $1.39 ($2.08)
Adjusted Weighted Average Diluted Shares Outstanding		 77.25M 25.99M 78.40M 77.96M 75.58M 25.85M 81.72M 82.28M 81.86M 82.16M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $3.03 $0.00 $0.00 $0.00 $0.48 $0.00 $0.00 $0.00 ($2.08)
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 77.25M 77.28M 77.37M 75.58M 75.59M 80.45M 80.47M 80.53M 80.88M 80.92M
Normalized Net Operating Profit after Tax (NOPAT)		 -130 68 40 36 2.17 31 129 57 136 -103
Normalized NOPAT Margin		 0.00% 48.46% 43.88% 51.59% 8.27% 83.65% 84.35% 69.84% 85.66% 0.00%
Pre Tax Income Margin		 0.00% 69.23% 62.68% 51.63% 8.56% 83.66% 84.36% 69.88% 85.67% 0.00%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 -2.23 0.94 0.48 0.27 0.02 0.24 1.07 0.47 1.06 -1.16
NOPAT to Interest Expense		 -1.56 0.91 0.48 0.27 0.02 0.24 1.07 0.47 1.06 -0.81
EBIT Less CapEx to Interest Expense		 -2.23 0.94 0.48 0.27 0.02 0.24 1.07 0.47 1.06 -1.16
NOPAT Less CapEx to Interest Expense		 -1.56 0.91 0.48 0.27 0.02 0.24 1.07 0.47 1.06 -0.81
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 -65.21% -70.46% -175.31% 7,044.03% 145.15% 198.67% 112.27% 89.62% 60.64% 126.80%
Augmented Payout Ratio		 -73.46% -79.99% -175.31% 7,741.26% 162.32% 224.92% 112.27% 92.77% 60.64% 126.80%

Frequently Asked Questions About Chimera Investment's Financials

When does Chimera Investment's financial year end?

According to the most recent income statement we have on file, Chimera Investment's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Chimera Investment's net income changed over the last 10 years?

Chimera Investment's net income appears to be on a downward trend, with a most recent value of $176.07 million in 2024, falling from $589.21 million in 2014. The previous period was $126.10 million in 2023. Find out what analysts predict for Chimera Investment in the coming months.

How has Chimera Investment revenue changed over the last 10 years?

Over the last 10 years, Chimera Investment's total revenue changed from $644.36 million in 2014 to $263.94 million in 2024, a change of -59.0%.

How much debt does Chimera Investment have?

Chimera Investment's total liabilities were at $10.59 billion at the end of 2024, a 2.1% increase from 2023, and a 31.9% decrease since 2014.

How much cash does Chimera Investment have?

In the past 10 years, Chimera Investment's cash and equivalents has ranged from $47.49 million in 2018 to $385.74 million in 2021, and is currently $84.00 million as of their latest financial filing in 2024.

How has Chimera Investment's book value per share changed over the last 10 years?

Over the last 10 years, Chimera Investment's book value per share changed from 3.51 in 2014 to 31.23 in 2024, a change of 789.5%.


Related Companies

This page (NYSE:CIM) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...
Timothy Sykes | Sponsored
Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored
Gold Alert: The Truth About Fort Knox Is Coming
Owning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...
Golden Portfolio | Sponsored
How to invest in Elon Musk’s Optimus before its launch
Elon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...
InvestorPlace | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Trump to solve American wealth loss?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...
Crypto 101 Media | Sponsored